产品名称 | NebuSelect™ Recombinant Mouse TRAIL/TNFRSF10, His-tag |
---|---|
目录号 | NBL-240610 |
别名 | TRAIL/TNFRSF10; Apo-2L; TRAIL; CD253; TNFSF10; Apo-2 ligand; APO2L; TL2 |
外观 | see COA |
分子量 | Pro118-Asn291 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P50592 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240610-100ug | 100ug | Inquire | Inquire | |
NBL-240610-1mg | 1mg | Inquire | Inquire | |
NBL-240610-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse TRAIL/TNFRSF10, His-tag
Catalog#:
NBL-240610
Description:
NebuSelect™ Recombinant Mouse TRAIL/TNFRSF10, His-tag(Cat#NBL-240610) is expressed in E.coli with His tag at the N-Terminus.It contains Pro118-Asn291.
Species:
Mouse
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 30.6 kDa same as Bis-Tris PAGE result.
Target Name:
TRAIL/TNFRSF10; Apo-2L; TRAIL; CD253; TNFSF10; Apo-2 ligand; APO2L; TL2
Target Information:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can initiate the apoptosis pathway by binding to its associated death receptors DR4 and DR5. The activation of the TRAIL pathway in inducing tumor-selective apoptosis leads to the development of TRAIL-based cancer therapies, which include recombinant forms of TRAIL, TRAIL receptor agonists, and other therapeutic agents.
Amino Acid Sequence:
Pro118-Asn291
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.